A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the the efficacy and safety of sintilimab in combination
with chemoradiation before surgery for esophageal cancer.